Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation

Patients with acute myeloid leukemia (AML) in morphological first complete remission (CR1) pre‐allogeneic hematopoietic cell transplantation (HCT) may have measurable residual disease (MRD) by molecular and immunophenotyping criteria. We assessed interactions of MRD status with HCT conditioning regi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of hematology 2018-09, Vol.93 (9), p.1142-1152
Hauptverfasser:	Gilleece, Maria H., Labopin, Myriam, Yakoub‐Agha, Ibrahim, Volin, Liisa, Socié, Gerard, Ljungman, Per, Huynh, Anne, Deconinck, Eric, Wu, Depei, Bourhis, Jean Henri, Cahn, Jean Yves, Polge, Emmanuelle, Mohty, Mohamad, Savani, Bipin N., Nagler, Arnon
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute myeloid leukemia Graft-versus-host reaction Hematology Leukemia Life Sciences Multivariate analysis Myeloid leukemia Remission Stem cell transplantation Toxicity Transplantation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!